SRDX - Surmodics, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Eden Prairie,
United States
Type: Equity
SRDX price evolution
SRDX
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $24.3 | $33.03 | $23.36 | |
| Short term investments | $13.87 | $7.91 | $11.82 | |
| Net receivables | $23.16 | $13.39 | $12.32 | $12.92 |
| Inventory | $15.17 | $15.4 | $15.4 | $14.44 |
| Total current assets | $81.3 | $80.36 | $84.26 | $79.81 |
| Long term investments | ||||
| Property, plant & equipment | $24.96 | $25.32 | $25.72 | $25.56 |
| Goodwill & intangible assets | $67.06 | $68.36 | $70.5 | |
| Total noncurrent assets | $97.06 | $98.54 | $100.43 | |
| Total investments | $13.87 | $7.91 | $11.82 | |
| Total assets | $178.56 | $177.41 | $182.81 | $180.24 |
| Current liabilities | ||||
| Accounts payable | $2.79 | $3.19 | $3.19 | $2.58 |
| Deferred revenue | $3.68 | $4.75 | $5.66 | |
| Short long term debt | ||||
| Total current liabilities | $20.54 | $20.2 | $19.2 | $16.48 |
| Long term debt | $29.55 | $29.52 | $29.48 | $29.44 |
| Total noncurrent liabilities | $39.07 | $39.66 | $41.61 | |
| Total debt | $29.52 | $29.48 | $29.44 | |
| Total liabilities | $59.66 | $59.27 | $58.85 | $58.09 |
| Shareholders' equity | ||||
| Retained earnings | $75.71 | $79.16 | $86.72 | $86.47 |
| Other shareholder equity | $118.9 | -$4.11 | -$3.75 | -$2.65 |
| Total shareholder equity | $118.14 | $123.95 | $122.15 | |
| (in millions $) | 30 Oct 2024 | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $41.42 | $19 | $31.15 | |
| Short term investments | $3.93 | $7.72 | ||
| Net receivables | $23.16 | $10.85 | $10.45 | $9.17 |
| Inventory | $15.17 | $14.84 | $11.82 | $6.76 |
| Total current assets | $81.3 | $86.69 | $57.59 | $70.25 |
| Long term investments | $2 | |||
| Property, plant & equipment | $24.96 | $26.03 | $27.15 | $30.09 |
| Goodwill & intangible assets | $69.15 | $68.86 | $82.66 | |
| Total noncurrent assets | $99.04 | $100.77 | $124.34 | |
| Total investments | $3.93 | $9.72 | ||
| Total assets | $178.56 | $185.73 | $158.36 | $194.59 |
| Current liabilities | ||||
| Accounts payable | $2.79 | $2.99 | $3.14 | $1.78 |
| Deferred revenue | $6.78 | $9.25 | $14.95 | |
| Short long term debt | $10 | $10 | ||
| Total current liabilities | $20.54 | $23.95 | $32.08 | $29.82 |
| Long term debt | $29.55 | $29.41 | ||
| Total noncurrent liabilities | $41.87 | $17.89 | $24.69 | |
| Total debt | $29.41 | $10 | $10 | |
| Total liabilities | $59.66 | $65.82 | $49.97 | $54.51 |
| Shareholders' equity | ||||
| Retained earnings | $75.71 | $87.25 | $88.79 | $116.06 |
| Other shareholder equity | $118.9 | -$4.76 | -$9.87 | $1.73 |
| Total shareholder equity | $119.91 | $108.39 | $140.09 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $33.23 | $30.34 | $31.96 | |
| Cost of revenue | $8.45 | $7.1 | ||
| Gross Profit | $24.55 | $21.89 | $24.86 | |
| Operating activities | ||||
| Research & development | $9.77 | $10.23 | ||
| Selling, general & administrative | $16.63 | $13.09 | ||
| Total operating expenses | $25.17 | $27.26 | $24.2 | |
| Operating income | -$5.37 | $0.66 | ||
| Income from continuing operations | ||||
| EBIT | -$4.93 | $1.05 | ||
| Income tax expense | $2.31 | $1.74 | -$0.08 | |
| Interest expense | $0.88 | $0.88 | ||
| Net income | ||||
| Net income | -$3.45 | -$7.55 | $0.25 | |
| Income (for common shares) | -$7.55 | $0.25 | ||
| (in millions $) | 30 Oct 2024 | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $126.08 | $99.95 | $105.14 | |
| Cost of revenue | $20.34 | $17.18 | ||
| Gross Profit | $93.05 | $79.61 | $87.96 | |
| Operating activities | ||||
| Research & development | $50.61 | $46.73 | ||
| Selling, general & administrative | $46.94 | $30.68 | ||
| Total operating expenses | $98.7 | $102.1 | $81.26 | |
| Operating income | -$22.49 | $6.7 | ||
| Income from continuing operations | ||||
| EBIT | -$21.89 | $6.66 | ||
| Income tax expense | $4.04 | $4.78 | $2.11 | |
| Interest expense | $0.6 | $0.31 | ||
| Net income | ||||
| Net income | -$11.54 | -$27.27 | $4.24 | |
| Income (for common shares) | -$27.27 | $4.24 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$7.55 | $0.25 | -$0.79 | |
| Operating activities | ||||
| Depreciation | $2.33 | $2.31 | $2.52 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.04 | $2.13 | $1.97 | |
| Total cash flows from operations | -$2.03 | $7.42 | -$8.79 | |
| Investing activities | ||||
| Capital expenditures | -$0.96 | -$1.27 | -$0.72 | |
| Investments | -$5.76 | $4.07 | -$7.75 | |
| Total cash flows from investing | -$2.94 | -$6.72 | $2.8 | -$8.47 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.09 | $0.53 | $0.04 | |
| Net borrowings | ||||
| Total cash flows from financing | -$2.95 | $0.07 | -$0.41 | -$1.05 |
| Effect of exchange rate | $0.34 | -$0.04 | -$0.13 | $0.25 |
| Change in cash and equivalents | -$5.3 | -$8.73 | $9.68 | -$18.06 |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$1.54 | -$27.27 | $4.24 | |
| Operating activities | ||||
| Depreciation | $9.17 | $9.67 | $8.32 | |
| Business acquisitions & disposals | -$40.55 | |||
| Stock-based compensation | $7.61 | $7.06 | $5.86 | |
| Total cash flows from operations | $10.51 | -$17.22 | $15.39 | |
| Investing activities | ||||
| Capital expenditures | -$2.92 | -$3.37 | -$5.28 | |
| Investments | -$3.9 | $9.6 | $20.59 | |
| Total cash flows from investing | -$2.94 | -$6.82 | $6.23 | -$25.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.25 | $1.25 | $3.13 | |
| Net borrowings | $19.05 | $10 | ||
| Total cash flows from financing | -$2.95 | $18.41 | -$0.38 | $10.23 |
| Effect of exchange rate | $0.34 | $0.32 | -$0.79 | -$0.01 |
| Change in cash and equivalents | -$5.3 | $22.42 | -$12.15 | $0.37 |
News
Fundamentals
| Market cap | $486.50M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 14.27M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 18.80% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.96 |
| Quick ratio | 3.22 |